Long-Acting Lipoglycopeptides

General Principles

Long-acting lipoglycopeptides are bactericidal antibiotics that inhibit bacterial cell wall biosynthesis, similar to vancomycin. Their spectrum of activity includes gram-positive aerobic pathogens only. These agents are characterized by extremely long terminal half-lives and are currently FDA-approved for skin/soft tissue infections.

There's more to see -- the rest of this topic is available only to subscribers.